Swedbank AB Acquires 130,000 Shares of Globe Life Inc. $GL

Swedbank AB boosted its holdings in shares of Globe Life Inc. (NYSE:GL) by 15.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 962,000 shares of the company’s stock after purchasing an additional 130,000 shares during the quarter. Swedbank AB’s holdings in Globe Life were worth $134,545,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in the company. Allianz Asset Management GmbH increased its position in shares of Globe Life by 55.2% during the 3rd quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock valued at $11,761,000 after purchasing an additional 29,256 shares during the last quarter. Retirement Systems of Alabama bought a new position in shares of Globe Life during the 3rd quarter valued at approximately $2,470,000. Pzena Investment Management LLC increased its position in shares of Globe Life by 5.6% during the 3rd quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock valued at $142,756,000 after purchasing an additional 52,523 shares during the last quarter. SG Americas Securities LLC increased its position in shares of Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock valued at $13,950,000 after purchasing an additional 89,866 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Globe Life by 11.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 247,947 shares of the company’s stock valued at $35,449,000 after purchasing an additional 24,785 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Insider Buying and Selling

In related news, EVP Robert Edward Hensley sold 712 shares of the company’s stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $142.59, for a total transaction of $101,524.08. Following the completion of the sale, the executive vice president directly owned 8,580 shares in the company, valued at $1,223,422.20. This represents a 7.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO James Matthew Darden sold 4,663 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $153.88, for a total value of $717,542.44. Following the sale, the chief executive officer owned 58,451 shares of the company’s stock, valued at $8,994,439.88. This trade represents a 7.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 106,550 shares of company stock valued at $16,140,745. Company insiders own 2.11% of the company’s stock.

Analyst Upgrades and Downgrades

GL has been the subject of a number of recent analyst reports. Piper Sandler upgraded Globe Life to a “strong-buy” rating in a report on Thursday, April 2nd. Morgan Stanley boosted their price objective on Globe Life from $176.00 to $181.00 and gave the company an “overweight” rating in a report on Thursday. Wells Fargo & Company boosted their price objective on Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a report on Friday, April 10th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Finally, Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Globe Life has an average rating of “Buy” and a consensus price target of $173.22.

Globe Life Price Performance

Shares of GL stock opened at $156.46 on Friday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $12.15 billion, a price-to-earnings ratio of 10.82 and a beta of 0.50. Globe Life Inc. has a twelve month low of $116.73 and a twelve month high of $157.92. The stock has a fifty day simple moving average of $147.24 and a two-hundred day simple moving average of $141.91.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The company had revenue of $1.56 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Globe Life had a return on equity of 20.94% and a net margin of 19.38%.The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter last year, the company earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. On average, analysts predict that Globe Life Inc. will post 15.57 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.